DRUG IMPORTATION FROM CANADA OR OTHER COUNTRIES WILL NOT FIX AMERICA’S BROKEN PRESCRIPTION DRUG SYSTEM
The latest idea to “fix” America’s broken prescription drug system is no fix at all. We, the pharmacists of Pharmacists United for Truth and Transparency, are calling out those who would have the nation believe the best way to deal with our country’s escalating medication cost crisis is to turn to another country in hopes of somehow “stimulating competition” as solution to a problem of our own making.
The complexities of prescription drug pricing notwithstanding, there are numerous reasons why drug importation is a bad idea:
We believe there are too many troubling questions remaining about the true role of PBM middlemen in America’s healthcare system. New stories emerge daily detailing eyebrow-raising practices including Medicaid spread pricing, audit abuse, forced mail order, patient steering to PBM-owned pharmacies and the negotiation and keeping of manufacturer rebates in exchange for inclusion on drug plan formularies.
We believe it is wrong that patients who look to their insurers to help keep prescription costs down must resort to juggling prescription discount cards and seeking copay assistance from patient advocacy groups and manufacturers.
To loosely paraphrase “Occam’s Razor”, the simplest solution is often the best solution. The simplest solution is transparency. Throwing back the veil of secrecy on the most opaque sections of the prescription drug supply chain allows everyone to know and understand how drugs are priced, including where and how price markups are determined, and what can be done to bring high prices back down to affordable levels.
America’s high drug price crisis can be fixed, and Americans should be the ones to fix it. We call on our country’s legislators, healthcare providers and healthcare business leaders to work together to resolve the problem within our own borders, not in the international arena to make American prescription drugs affordable again.